ONC
Beone Medicines·NASDAQ
--
--(--)
--
--(--)
ONC fundamentals
Beone Medicines (ONC) Revenue Breakdown: Q3 2025 Business & Regional Performance
Beone Medicines (ONC) reported total revenue of 1.41B USD in Q3 2025, with its core business segment Product contributing 98.78%. Regionally, United States remained the largest market, accounting for 53.45% of total revenue. Explore Beone Medicines's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
Beone Medicines (ONC) reported total revenue of 1.41B USD in Q3 2025, with its core business segment Product contributing 98.78%. Regionally, United States remained the largest market, accounting for 53.45% of total revenue. Explore Beone Medicines's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
By Business
No Data
By Region
No Data
You can ask Aime
What were the key takeaways from Beone Medicines's earnings call?What is the revenue and EPS growth rate for Beone Medicines year over year?What does Beone Medicines do and what are its main business segments?What guidance did Beone Medicines's management provide for the next earnings period?What is Beone Medicines's gross profit margin?What is Beone Medicines's latest dividend and current dividend yield?What factors drove the changes in Beone Medicines's revenue and profit?What is the market's earnings forecast for Beone Medicines next quarter?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
